ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/23 | 1,645 | 1,682 | 1,634 | 1,643 | -16 | -1% | 780,900 |
| 2022/08/22 | 1,663 | 1,682 | 1,623 | 1,659 | -41 | -2.4% | 1,115,000 |
| 2022/08/19 | 1,730 | 1,749 | 1,652 | 1,700 | -29 | -1.7% | 2,135,200 |
| 2022/08/18 | 1,815 | 1,815 | 1,707 | 1,729 | -135 | -7.2% | 2,115,800 |
| 2022/08/17 | 1,950 | 1,965 | 1,854 | 1,864 | -113 | -5.7% | 2,108,000 |
| 2022/08/16 | 1,843 | 2,015 | 1,831 | 1,977 | +187 | +10.4% | 3,356,200 |
| 2022/08/15 | 1,792 | 1,830 | 1,762 | 1,790 | -16 | -0.9% | 1,019,000 |
| 2022/08/12 | 1,774 | 1,822 | 1,755 | 1,806 | +22 | +1.2% | 1,095,100 |
| 2022/08/10 | 1,988 | 1,990 | 1,767 | 1,784 | -185 | -9.4% | 2,421,500 |
| 2022/08/09 | 1,863 | 1,975 | 1,858 | 1,969 | +111 | +6% | 1,502,000 |
| 2022/08/08 | 1,811 | 1,866 | 1,785 | 1,858 | +23 | +1.3% | 902,700 |
| 2022/08/05 | 1,890 | 1,908 | 1,825 | 1,835 | -48 | -2.5% | 1,139,500 |
| 2022/08/04 | 1,860 | 1,904 | 1,851 | 1,883 | +58 | +3.2% | 1,334,400 |
| 2022/08/03 | 1,820 | 1,867 | 1,807 | 1,825 | +43 | +2.4% | 1,192,100 |
| 2022/08/02 | 1,735 | 1,826 | 1,734 | 1,782 | -6 | -0.3% | 1,191,800 |
| 2022/08/01 | 1,850 | 1,859 | 1,748 | 1,788 | -75 | -4% | 1,500,200 |
| 2022/07/29 | 1,792 | 1,893 | 1,779 | 1,863 | +88 | +5% | 2,070,400 |
| 2022/07/28 | 1,745 | 1,786 | 1,708 | 1,775 | +29 | +1.7% | 1,510,100 |
| 2022/07/27 | 1,625 | 1,757 | 1,625 | 1,746 | +134 | +8.3% | 1,857,800 |
| 2022/07/26 | 1,544 | 1,615 | 1,537 | 1,612 | +62 | +4% | 517,600 |
| 2022/07/25 | 1,558 | 1,587 | 1,524 | 1,550 | -30 | -1.9% | 603,900 |
| 2022/07/22 | 1,558 | 1,594 | 1,533 | 1,580 | +1 | +0.1% | 624,500 |
| 2022/07/21 | 1,526 | 1,624 | 1,524 | 1,579 | +51 | +3.3% | 1,376,700 |
| 2022/07/20 | 1,497 | 1,547 | 1,468 | 1,528 | +2 | +0.1% | 885,200 |
| 2022/07/19 | 1,498 | 1,555 | 1,422 | 1,526 | +110 | +7.8% | 2,297,500 |
| 2022/07/15 | 1,387 | 1,452 | 1,367 | 1,416 | +41 | +3% | 1,125,800 |
| 2022/07/14 | 1,272 | 1,375 | 1,258 | 1,375 | +101 | +7.9% | 688,600 |
| 2022/07/13 | 1,266 | 1,281 | 1,253 | 1,274 | -5 | -0.4% | 225,500 |
| 2022/07/12 | 1,255 | 1,293 | 1,253 | 1,279 | +2 | +0.2% | 333,500 |
| 2022/07/11 | 1,303 | 1,310 | 1,276 | 1,277 | -7 | -0.5% | 235,500 |
| 2022/07/08 | 1,290 | 1,306 | 1,263 | 1,284 | +17 | +1.3% | 452,600 |
| 2022/07/07 | 1,273 | 1,295 | 1,255 | 1,267 | -3 | -0.2% | 350,200 |
| 2022/07/06 | 1,246 | 1,286 | 1,245 | 1,270 | +44 | +3.6% | 495,900 |
| 2022/07/05 | 1,227 | 1,257 | 1,222 | 1,226 | -1 | -0.1% | 282,600 |
| 2022/07/04 | 1,250 | 1,250 | 1,217 | 1,227 | -5 | -0.4% | 266,800 |
| 2022/07/01 | 1,270 | 1,288 | 1,222 | 1,232 | -30 | -2.4% | 512,300 |
| 2022/06/30 | 1,307 | 1,313 | 1,262 | 1,262 | -46 | -3.5% | 317,300 |
| 2022/06/29 | 1,300 | 1,310 | 1,280 | 1,308 | -12 | -0.9% | 290,900 |
| 2022/06/28 | 1,285 | 1,336 | 1,279 | 1,320 | +43 | +3.4% | 524,000 |
| 2022/06/27 | 1,311 | 1,315 | 1,272 | 1,277 | -40 | -3% | 574,900 |
| 2022/06/24 | 1,266 | 1,323 | 1,263 | 1,317 | +81 | +6.6% | 910,900 |
| 2022/06/23 | 1,189 | 1,254 | 1,178 | 1,236 | +55 | +4.7% | 645,600 |
| 2022/06/22 | 1,239 | 1,240 | 1,170 | 1,181 | -39 | -3.2% | 415,900 |
| 2022/06/21 | 1,185 | 1,235 | 1,178 | 1,220 | +59 | +5.1% | 559,500 |
| 2022/06/20 | 1,170 | 1,206 | 1,146 | 1,161 | +12 | +1% | 369,100 |
| 2022/06/17 | 1,121 | 1,160 | 1,117 | 1,149 | -15 | -1.3% | 573,300 |
| 2022/06/16 | 1,206 | 1,207 | 1,163 | 1,164 | -17 | -1.4% | 309,600 |
| 2022/06/15 | 1,171 | 1,184 | 1,149 | 1,181 | +12 | +1% | 346,900 |
| 2022/06/14 | 1,168 | 1,178 | 1,136 | 1,169 | -26 | -2.2% | 527,200 |
| 2022/06/13 | 1,171 | 1,195 | 1,151 | 1,195 | -1 | -0.1% | 586,700 |
651～
700
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 222,700円 | +21.7% | +999.9% | 0.00% | 9.27倍 | 3.07倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 450,000円 | +7.1% | -35.0% | 2.67% | 37.21倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 230,400円 | +14.2% | +41.0% | 2.00% | 11.28倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 306,500円 | +3.0% | +27.5% | 2.61% | 19.40倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
